1. Home
  2. BCTX vs PT Comparison

BCTX vs PT Comparison

Compare BCTX & PT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCTX
  • PT
  • Stock Information
  • Founded
  • BCTX 2014
  • PT 2012
  • Country
  • BCTX Canada
  • PT China
  • Employees
  • BCTX N/A
  • PT N/A
  • Industry
  • BCTX Biotechnology: Pharmaceutical Preparations
  • PT Computer Software: Programming Data Processing
  • Sector
  • BCTX Health Care
  • PT Technology
  • Exchange
  • BCTX Nasdaq
  • PT Nasdaq
  • Market Cap
  • BCTX 13.7M
  • PT 15.2M
  • IPO Year
  • BCTX N/A
  • PT 2018
  • Fundamental
  • Price
  • BCTX $0.69
  • PT $0.90
  • Analyst Decision
  • BCTX Strong Buy
  • PT
  • Analyst Count
  • BCTX 1
  • PT 0
  • Target Price
  • BCTX $32.00
  • PT N/A
  • AVG Volume (30 Days)
  • BCTX 2.1M
  • PT 12.6K
  • Earning Date
  • BCTX 06-16-2025
  • PT 08-19-2025
  • Dividend Yield
  • BCTX N/A
  • PT N/A
  • EPS Growth
  • BCTX N/A
  • PT N/A
  • EPS
  • BCTX N/A
  • PT N/A
  • Revenue
  • BCTX N/A
  • PT $4,814,566.00
  • Revenue This Year
  • BCTX N/A
  • PT N/A
  • Revenue Next Year
  • BCTX N/A
  • PT N/A
  • P/E Ratio
  • BCTX N/A
  • PT N/A
  • Revenue Growth
  • BCTX N/A
  • PT N/A
  • 52 Week Low
  • BCTX $0.61
  • PT $0.76
  • 52 Week High
  • BCTX $29.40
  • PT $1.15
  • Technical
  • Relative Strength Index (RSI)
  • BCTX 21.33
  • PT 42.53
  • Support Level
  • BCTX $0.61
  • PT $0.89
  • Resistance Level
  • BCTX $0.78
  • PT $0.98
  • Average True Range (ATR)
  • BCTX 0.05
  • PT 0.05
  • MACD
  • BCTX 0.07
  • PT -0.00
  • Stochastic Oscillator
  • BCTX 34.43
  • PT 9.09

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.

About PT Pintec Technology Holdings Limited

Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees, as well as by providing financing for these borrowers and earning installment service fees. The company earns wealth management services fees and commissions on financial products. The company generates the majority of its revenue from Wealth management service fees and others.

Share on Social Networks: